These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9172968)

  • 41. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response.
    Winokur A; Caroff SN; Amsterdam JD; Maislin G
    Biol Psychiatry; 1984 May; 19(5):695-702. PubMed ID: 6428472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment for acute lymphoblastic leukemia in children is associated with papillary carcinoma of thyroid, but not with thyroid disfunction.
    Neves Mascarenhas A; Papadia C; Alves Aquino C; Oba L; Ferreira M; Casulari LA
    Minerva Pediatr; 2006 Oct; 58(5):469-76. PubMed ID: 17008858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sexual impotence: studies of the hypothalamic-pituitary-thyroid axis and the effect of oral thyrotropin-releasing factor.
    Benkert O; Horn K; Pickardt CR; Schmid D
    Arch Sex Behav; 1976 Jul; 5(4):269-74. PubMed ID: 182105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypothalamic-pituitary-end organ function in women with bipolar depression.
    Rasgon NL; Kenna HA; Wong ML; Whybrow PC; Bauer M
    Psychoneuroendocrinology; 2007 Apr; 32(3):279-86. PubMed ID: 17317022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The hypothalamic-pituitary-thyroid axis in subjects with subclinical thyroid diseases: the impact of the negative feedback mechanism.
    Falaschi P; Martocchia A; Proietti A; D'Urso R; Gargano S; Culasso F; Rocco A
    Neuro Endocrinol Lett; 2004 Aug; 25(4):292-6. PubMed ID: 15361820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
    Rechlin T
    J Clin Psychopharmacol; 1994 Dec; 14(6):392-5. PubMed ID: 7884019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular effects of fluvoxamine and maprotiline in depressed patients.
    Hewer W; Rost W; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):1-6. PubMed ID: 8773212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of 100 micrograms TRH intravenously and 40 mg TRH orally in euthyroidism (author's transl)].
    Passath A; Stradner F; Petritsch W; Goebel ; Leb G
    Acta Med Austriaca; 1981; 8(3):75-81. PubMed ID: 6791450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts.
    Vescovi PP; Pezzarossa A
    Neuropeptides; 1999 Dec; 33(6):522-5. PubMed ID: 10657535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: influence of weight recovery.
    Kiyohara K; Tamai H; Takaichi Y; Nakagawa T; Kumagai LF
    Am J Clin Nutr; 1989 Oct; 50(4):767-72. PubMed ID: 2508460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The hypothalamic-pituitary-thyroid axis in major depression.
    Sullivan PF; Wilson DA; Mulder RT; Joyce PR
    Acta Psychiatr Scand; 1997 May; 95(5):370-8. PubMed ID: 9197900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppressive effects of dexamethasone on hypothalamic-pituitary-thyroid axis function in depressed patients.
    Maes M; Vandewoude M; Schotte C; Martin M; Blockx P
    J Affect Disord; 1990 Sep; 20(1):55-61. PubMed ID: 2147190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.
    Bschor T; Baethge C; Adli M; Lewitzka U; Eichmann U; Bauer M
    J Psychiatry Neurosci; 2003 May; 28(3):210-6. PubMed ID: 12790161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter evaluation of maprotiline hydrochloride for treatment of depression.
    Clin Ther; 1984; 6(2):155-62. PubMed ID: 6367987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypercalcemia influences TRH-stimulated TSH and T3 response.
    Zofková I; Blahos J; Bednár J
    Endokrinologie; 1981 Dec; 78(2-3):186-90. PubMed ID: 6800777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
    Kasper S; Dötsch M; Kick H; Vieira A; Möller HJ
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):13-21. PubMed ID: 8471827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.